Skip to main content

Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease

The Original Article was published on 28 June 2017

Correction to: Acta Neuropathologica Communications (2017) 5:53 https://doi.org/10.1186/s40478-017-0456-2

Following publication of the original article [1], the author identified an error in Fig. 4E. The data and statistics were correct, but the synaptophysin blot was incorrect.

The incorrect (Fig. 1) and correct figure (Fig. 2) are shown in this correction article.

Fig. 1
figure1

Incorrect version of Fig. 4E as originally published

Fig. 2
figure2

Correct version of Fig. 4E

Reference

  1. 1.

    Finkelstein DI, Billings JL, Adlard PA et al (2017) The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease. Acta Neuropathol Commun 5:53. https://doi.org/10.1186/s40478-017-0456-2

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to David I. Finkelstein or Robert A. Cherny.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Finkelstein, D.I., Billings, J.L., Adlard, P.A. et al. Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease. acta neuropathol commun 9, 161 (2021). https://doi.org/10.1186/s40478-021-01258-8

Download citation